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Parkinson's diseaseWe tested the hypothesis that both VMAT-2 and DT-diaphorase are an important cellular defense against
aminochrome-dependent neurotoxicity during dopamine oxidation. A cell line with VMAT-2 and DT-
diaphorase over-expressed was created. The transfection of RCSN-3 cells with a bicistronic plasmid coding
for VMAT-2 fused with GFP-IRES-DT-diaphorase cDNA induced a signiﬁcant increase in protein expression
of VMAT-2 (7-fold; Pb0.001) and DT-diaphorase (9-fold; Pb0.001), accompanied by a 4- and 5.5-fold signif-
icant increase in transport and enzyme activity, respectively. Studies with synaptic vesicles from rat substan-
tia nigra revealed that VMAT-2 uptake of 3H-aminochrome 6.3±0.4nmol/min/mg was similar to dopamine
uptake 6.2±0.3 nmol/min/mg that which were dependent on ATP. Interestingly, aminochrome uptake was
inhibited by 2 μM lobeline but not reserpine (1 and 10 μM). Incubation of cells overexpressing VMAT-2 and
DT-diaphorase with 20 μM aminochrome resulted in (i) a signiﬁcant decrease in cell death (6-fold,
Pb0.001); (ii) normal ultra structure determined by transmission electron microscopy contrasting with a sig-
niﬁcant increase of autophagosome and a dramatic remodeling of the mitochondrial inner membrane in wild
type cells; (iii) normal level of ATP (256±11 μM) contrasting with a signiﬁcant decrease in wild type cells
(121±11 μM, Pb0.001); and (iv) a signiﬁcant decrease in DNA laddering (21±8 pixels, Pb0.001) cells in
comparison with wild type cells treated with 20 μM aminochrome (269±9). These results support our hy-
pothesis that VMAT-2 and DT-diaphorase are an important defense system against aminochrome formed
during dopamine oxidation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Vesicular monoamine transporter-2 (VMAT-2) is able to take up
dopamine into monoaminergic vesicles by using a vesicular proton
pump associated to ATPase that under hydrolysis of ATP to ADP
and Pi one proton (H+) is translocated into the vesicle, generating
an electrochemical gradient of protons. VMAT-2 uses this electro-
chemical gradient to take up one molecule of dopamine by releasing
2 protons [1,2]. This electrochemical gradient creates a low pH envi-
ronment inside the monoaminergic vesicles estimated to be 2 to 2.4
pH units lower than in the cytosol [3], where the protons of dopa-
mine hydroxyl groups are very hard bound to the oxygen, preventing
dopamine oxidation. However, in the cytosol the protons of dopa-
mine hydroxyl groups can dissociate and in the presence of oxygen
dopamine oxidizes spontaneously without the necessity of metal-
ion catalysis [4]. Dopamine oxidation to aminochrome catalyzed byharmacology, ICBM, Faculty of
+56 2 978 6057; fax: +56 2
uilar).
rights reserved.oxygen is accompanied with the formation of superoxide radicals
that can enzymatically or spontaneously generate hydrogen perox-
ide, the precursor of hydroxyl radicals. This oxidative mechanism
of dopamine can be potentiated by drugs such as methamphetamine.
VMAT-2 is able to take up methamphetamine into monoaminergic
vesicles, inducing the release of dopamine to the cytosol that is an
important event for methamphetamine neurotoxicity. The role of cy-
tosolic dopamine in methamphetamine neurotoxicity has been sup-
ported by the fact that the inhibition of dopamine synthesis protects
against methamphetamine neurotoxicity while the inhibition of
VMAT-2 and monoamine oxidase exacerbate methamphetamine
neurotoxicity [for review see 5].
Dopamine oxidation to aminochrome and its polymerization to
neuromelanin seems to be a natural occurring process which accu-
mulates with age [6,7]. Motor symptoms in Parkinson's disease are
primarily the result from a selective loss of the neuromelanin-
containing dopaminergic neurons of the substantia nigra while the
unpigmented dopaminergic neurons are spared [8,9]. However, the
question is why melanin containing dopaminergic neurons degener-
ate during Parkinson's disease when the neuromelanin formation it-
self is not neurotoxic. One possible explanation is that aminochrome
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of adducts with alpha synuclein to produce and stabilize the forma-
tion of neurotoxic protoﬁbers [10,11]; (ii) inducing mitochondrial
dysfunction [12]; (iii) inactivation of proteosomal system [13,14];
(iv) disruption of cytoskeleton architecture [15]; and (v) formation
of reactive oxygen species [16].
A complete knockout of VMAT2 (−/−) induces that mice move lit-
tle, feed poorly, and die within a few days after birth while amphet-
amine increases movement, promotes feeding, and prolongs their
survival [17]. VMAT2-deﬁcient animals have decreased motor function,
progressive deﬁcits in olfactory discrimination, shorter latency to behav-
ioral signs of sleep, delayed gastric emptying, anxiety-like behaviors at
younger ages, and a progressive depressive-like phenotype [18]. Over-
expression of VMAT-2 decreases cytosolic dopamine and inhibit neuro-
melanin synthesis, preventing dopamine oxidation to o-quinones [19].
Experiments done with human brain tissues support this idea since
they found an inverse relationship between the level of expression of
VMAT-2 and the amount of neuromelanin and the vulnerability to neu-
rodegeneration in Parkinson's disease [20]. Therefore, VMAT-2 should
play a protective role in dopaminergic neuron by preventing dopamine
oxidation in the cytosol to aminochrome.
DT-Diaphorase (EC.1.6.99.2) is the unique ﬂavoenzymes that cata-
lyzes the two-electron reduction of aminochrome to leukoamino-
chrome and that can use both NADH and NADPH as electron
donators [21]. This reaction is neuroprotective since it prevents one-
electron reduction to leukoaminochrome o-semiquinone radical that
it's extremely reactive with oxygen and neurotoxic [15,16,22–24].
DT-Diaphorase has been reported to prevent the cytoskeleton disrup-
tion [15], mitochondria damage [16,24], the formation of alpha synu-
clein protoﬁbrils [25,26] and protects against aminochrome-induced
proteasome inhibition [13]. Therefore, the aim of this work was to in-
vestigate the possible protective role of both of VMAT-2 and DT-
diaphorase against aminochrome neurotoxicity by creating a cell
line with high expression of VMAT-2 and DT-diaphorase.2. Materials and methods
2.1. Chemicals
Dopamine, reserpine, dicoumarol, DME/HAM-F12 nutrient mixture
(1:1) and Dulbecco's phosphate buffered saline (PBS) were purchased
from Sigma Chemical Co. (St Louis. MO. USA). Lobeline was obtained
from Fluka. Calcein AM and ethidium homodimer-1 were obtained
fromMolecular Probe (Eugene. OR. USA). Thermoscript RT-PCR system
and Taq DNA polymerase were obtained from Life Technologies (Cali-
fornia. USA). Trizol reagent was obtained from Invitrogen (California.
USA). The primers were obtained from T-A-G-Copenhagen A/S (Copen-
hagen. Denmark).2.2. Preparation of synaptic vesicles and uptake
The puriﬁcation of presynaptic vesicles was performed by using a
Synaptic Vesicles Isolation KIT (Sigma-Aldrich Co., St. Louis. USA).
After the gradient centrifugation, the protein concentration of the
fraction containing synaptic vesicles was determined by Bradford
method. Synaptic vesicles (2.5 μg protein) were incubated at 37 °C
during 0, 60, 90 and 120 min in a buffer containing 25 mM HEPES,
100 mM potassium tartrate, 100 mM sodium tartrate, 1.7 mM ascor-
bic acid, 0.05 mM EGTA, 0.1 mM EDTA, and 2 mM ATP-Mg+2 at pH
7.5 in the presence of 50 nM 3H-dopamine or 3H-aminochrome. The
samples were ﬁltrated with a Sephadex G-25 to remove extracellular
3H-dopamine or 3H-aminochrome. The vesicles were disrupted by
adding RIPA buffer and the isotopes were measured the counts per
minute by using scintillate instrument.2.3. Cell culture
The RCSN-3 cell line was derived from the substantia nigra of a 4-
month-old normal Fisher 344 rat. The RCSN-3 cell line grows in
monolayer with a doubling time of 52 h at a plating efﬁciency of
21% and a saturation density of 56,000 cells/cm2 when kept in normal
growth media composed of: DME/HAM-F12 (1:1), 10% bovine serum,
2.5% fetal bovine serum, and 40 mg/l gentamicine sulfate [27,28]. Cul-
tures were kept in an incubator at 37 °C with 100% humidity and an
atmosphere of 10% CO2.
2.4. Cell transfection
The OmicsLink™ bicistronic plasmid pVMAT2GFPDTwith internal
ribosome entry site (IRES) was used as expression vector systems of
human synaptic vesicle monoamine transporter (accession no.:
L09118), 1545 bp length fused in the C-terminal with GFP and
Homo sapiens DT-diaphorase (NAD(P)H dehydrogenase quinone;
accession no: NM_000903), and 825 bp length (GeneCopoeia). The
transfection solutions was prepared by mixing 50 mM HEPES buffer,
30 mM NaCl, 1.5 mM Na2HPO4 pH 6.9, DNA plasmid and 2.5 M CaCl2
and incubated at room temperature during 20 min. RCSN-3 cells in
60% conﬂuence were transfected with this solution added slowly
and mixing gently. The cells were incubated during 48 to 72 h at
37 °C.
2.5. Dot blot
Dot blots were performed by using a Bio-Rad Bio-Dot dot-blot appa-
ratus assembled with a nitrocellulose membrane that previously was
immersed in 20 mM Tris pH 7.6 containing 136 mM NaCl was added
to each well before the addition of 50–200 μl samples containing
50 μg protein. The vacuum connected to the dot blot equipment is
allowed to continue until themembrane is dry. The nitrocellulosemem-
brane was blocked by incubating them in 20 mMTris pH 7.6 containing
136 mM NaCl, 0.1% Tween 20, low fat milk 5% during 3 h at room tem-
perature with gently shaking. Wash the membrane 3 times during
5 min by using a solution of 20 mM Tris pH 7.6 containing 136 mM
NaCl, 0.1% Tween 20. Incubate the membrane in a solution of 20 mM
Tris pH 7.6 containing 136 mM NaCl, 0.1% Tween 20, 5% BSA and poly-
clonal antibodies against DT-diaphorase diluted 1:1000 (SC-7012,
Santa Cruz Biotechnology Inc). VMAT-2 diluted 1:1000 (AB1767, Milli-
pore Chemicon) and actin diluted 1:1000 (SC-1615, Santa Cruz Biotech-
nology Inc). The membrane were washed 3 times 5 min and incubated
in 20 mM Tris pH 7.6 containing 136 mM NaCl, 0.1% Tween 20, 5% BSA
and secondary antibody conjugatedwith HRP (horseradish peroxidase)
diluted 1:10,000. The quantiﬁcation of dot blot bandswas performed by
scanning the nitrocellulose membranes with scion image program
(NIH) and they were expressed as pixels.
2.6. Determination of GFP ﬂuorescence with confocal microscopy
Cover slips were mounted on to slides with ﬂuorescent mounting
medium (Dako, Carpinteria, CA. USA) and kept in the dark at 4 °C.
Confocal microscopy (Zeiss, Göttingen. Germany; model LSM-410
Axiovert-100) was used to study the cells. Sample illumination was
carried out via a He–Ne laser with 543-nm excitation ﬁlter and emis-
sion ﬁlter over 560 nm. The nuclei were marked with DAPI staining.
2.7. VMAT-2 activity determination
VMAT-2 activity was determined bymeasuring 3H-dopamine trans-
port in RCSN-3 and RCSN3VMATGFPDT cells with stable overexpression
of VMAT2. The cells were harvested and collected by centrifugation
(2000 rpm for 5 min) in PBS, resuspended at 1.25×106 cells/ml in KT-
HEPES buffer (25 mM HEPES; 100 mM potassium tartrate; 0.1 mM
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perature for 10 min. Cells were then collected by centrifugation
(3000 rpm for 5 min) and resuspended at 1.25×106 cells/ml in KT-
HEPES buffer. For [3H]dopamine uptake, the cell suspension (200 μl)
was incubated with KT-HEPES buffer containing 5 mM ATP-Mg2+ and
50 nM [3H]dopamine at temperature 37 °C for 45 min and the reaction
terminated at 12,500 rpm for 15 min at 0 °C followed by addition of
0.1% SDS to each cell pellet. Non-speciﬁc uptake was determined with
RCSN-3 cells wild type in the presence of 10 μM tetrabenazine (Ameri-
can Radiolabeled Chemicals. Inc., St. Louis. MO). Radioactivity was
quantiﬁed with a scintillation spectrometer. The data was normalized
by measuring protein concentration with Biuret method.
2.8. DT-Diaphorase activity determination
DT-Diaphorase activity in RCSN-3 and RCSN3VMAT2GFPDT was
determined in Tris/HCl buffer at pH 7.5 containing 0.08% Triton X-
100 by using 500 μM NADH or 500 μM NADPH as electron donor,
77 μM cytochrome C and 10 μM menadione as electron acceptor.
The reaction was measured spectrophotometrically by following the
reduction of cytochrome C, which continuously reoxidize the reduced
menadione at 550 nm and employing an extinction coefﬁcient of
18.5 mM−1 cm−1. DT-Diaphorase activity was calculated by inhibit-
ing the quinone reductase activity with dicoumarol [29].
2.9. Cell death determination
The cells were incubated with cell culture medium but in the ab-
sence of bovine serum and phenol red for 24 h. The concentration
used for toxicity experiments was 20 μM aminochrome in theTime (min)
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Fig. 1. Dopamine and aminochrome uptake into synaptic vesicles. (A) The uptake of dopami
by incubating the vesicles with 50 nM 3H-dopamine or 3H-aminochrome. Brain synaptic vesi
and 120 min as described under Materials and methods; (B) dopamine uptake inhibition in
uptake was measured at different aminochrome concentrations (0, 0.01, 0.5, 1, 10, 50, 100 μ
10 μM aminochrome. As positive control of dopamine uptake inhibition was used 50 μM (C+
synaptic vesicles was determined at 120 min in the presence of cell culture medium (C); 1 μ
of lobeline on uptake of 3H-dopamine or 3H-aminochrome into rat substantia nigra synaptic
in the presence of 2 μM lobeline at 37 °C (L) or at 4 °C (L 4 °C). The values are the mean±SD
Student's t test (***Pb0.001; **Pb0.01; *Pb0.05).presence or absence of 100 μM dicoumarol or 2 μM lobeline. For con-
trol conditions, we used 20 μM aminochrome, 2 μM lobeline or
100 μM dicoumarol incubated alone. The cells were visualized at
100× magniﬁcation in a Nikon Diaphot inverted microscope
equipped with phase contrast and ﬂuorescence optics. The toxicity
was measured by counting live and dead cells after staining with
0.5 μM Calcein AM and 5 μM ethidium homodimer-1 for 45 min at
37 °C in the darkness. Calcein AM is a marker for live cells and ethi-
dium homodimer-1 that intercalates in the DNA of dead cells is a
marker for cell death. The cells were counted in a phase contrast mi-
croscope equipped with ﬂuorescence, using the following ﬁlters:
Ethidium homodimer-1 510–560 nm (excitation) and LP-590 nm
(emission); Calcein AM 450–490 nm (excitation) and 515–565 nm
(emission). For experiments to study autophagy effect on cell death
the cells were incubated with 10 μM vinblastine or 10 μM rapamycin.
2.10. Transmission electron microscopy
After the treatments, RCSN-3 and RCSN3VMAT2GFPDT cells were
washed three times with PBS pH 7.4 and ﬁxed in 3% glutaraldehyde
for 240 min, washed 3 times and post-ﬁxed in osmium tetra oxide
2% for 60 min at room temperature. The cells were dehydrated in
an ascending ethanol battery ranging from 20 to 100% and were
later placed in 100% ethanol for 10 min and ﬁnally embedding in
epon-812 resin. Ultrathin sections were made and impregnated
with 4% uranyl acetate and Reynold's lead citrate. The sections
were visualized in a Zeiss EM-900 transmission electron microscope
at 50 kV photographed, the negatives were scanned at 600×600 ppi
resolution and the images obtained were analyzed later in a PC com-
patible computer using customized software.0 0.01 0.50 1 10 50 100 C+
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ne and aminochrome into synaptic vesicles was measured in rat brain synaptic vesicles
cles are able to take up both dopamine and aminochrome at similar rate during 0, 60, 90
to rat substantia nigra synaptic vesicles in the presence of aminochrome. 3H-Dopamine
M). 3H-Dopamine uptake was inhibited by aminochrome at concentration higher than
); (C) the effect of reserpine on 3H-Dopamine or 3H-aminochrome uptake in rat brain
M reserpine at 37 °C (R) at 4 °C (R 4 °C) or in the absence of ATP (R-ATP); (D) the effect
vesicles was determined at 120 min at 37 °C in the presence of cell culture medium (C);
and the statistical signiﬁcance was assessed using ANOVA for multiple comparisons and
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Cells were grown in culture medium in 24-well plates for 48 h
after being transfected with green ﬂuorescent-protein light chain
3 (GFP-LC3) plasmid (gift from Zsolt Tallocky PhD, Columbia University
Medical Center). To form the transfection complex, we used 2 μl Fugene
HD transfection reagent (Roche Diagnostics) and 0.5 μg GFP-LC3 plas-
mid DNA in 25 μl total volume of medium for each plate, kept in the
dark for 15 min. Thereafter, the transfection complex in 150 μl culture
medium was added to each plate and incubated for 1 h. Then, 350 μl
culture medium was added to each plate and cultured for two days.
The cells were analyzed by using a confocal microscopy.DT-diaphorase
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Fig. 2. Over-expression of VMAT-2 and DT-diaphorase in RCSN-3 cells. (A) The expression of
determined by using dot blot technique. As control RCSN-3 cells (WT) and RCSN-3 transfec
were used to determine their expression as described under Materials and methods. (C) Qu
software Scion Image (NIH) and the values correspond to pixels of DT-diaphorase or VMAT-
cells (right) contrasts with the lack of ﬂuorescence in RCSN-3 cells (left). The nucleus was sta
bar=10 μm); (E) DT-diaphorase activity was determined by using NADH and menadione as
activity was determined by using 3H-dopamine as described in Materials and methods. Th
dent's t test (***Pb0.001).2.12. DNA isolation and quantitative polymerase chain reaction (QPCR)
of nuclear DNA (nDNA) fragment
Cells were isolated as previously described [23]. QPCR method to
detect nuclear DNA damage was performed as previously described
[30,31,23]
2.13. DNA fragmentation
RCSN-3 and RCSN3VMAT2GFPDT cells were incubated with 20 μM
aminochrome; 20 μM aminochrome and 100 μM dicoumarol; 20 μM
aminochrome and 2 μM lobeline. As control the cells were treatedDT-diaphorase VMAT-2
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antiﬁcation of expression of VMAT-2 and DT-diaphorase were determined by using the
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Fig. 3. Aminochrome induced cell death in RCSN-3 RCSN-3-GFP and RCSN-
3VMAT2GFPDT and cell lines in the presence of aminochrome, dicoumarol and lobe-
line. The cell death was determined in RCSN-3, RCSN-3-GFP or RCSN3VMAT2GFPDT
cells incubated during 24 h with cell culture medium (C) 20 μM aminochrome (AM)
20 μM aminochrome and 100 μM dicoumarol (AMD) 20 μM aminochrome and 2 μM lo-
beline (AML) as described under Materials and methods. Our results show that
RCSN3VMAT2GFPDT cells overexpressing VMAT-2 and DT-diaphorase are resistant to
aminochrome neurotoxicity. The statistical signiﬁcance was assessed using ANOVA
for multiple comparisons and Student's t test (***Pb0.001).
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removed and the cells were incubated in 90 μl 10% SDS and 810 μl
buffer TE (10 mM Tris HCl, 1 mM EDTA, pH 8) for 2–5 min at room
temperature. The extracted cells were placed in a tube containing
900 μl saturated phenol and centrifuged at 14,000 rpm for 10 min at
4 °C. The aqueous phase was extracted by addition of 900 μl of satu-
rated phenol and centrifuged at 14,000 rpm for 10 min at 4 °C. This
procedure was performed twice. The aqueous phase was mixed
with 900 μl 24:1 chloroform: isoamilic ethanol and centrifuged at
14,000 rpm for 10 min 4 °C. The aqueous phase was removed and
resuspended in 90 μl 3 M sodium acetate pH 5.2 and isopropanol to
ﬁll the tube, incubated at −20 °C for 24 h and centrifuged at
14,000 rpm for 15 min at 4 °C. The pellet was resuspended in 70% eth-
anol and centrifuged at 14,000 rpm for 10 min at 4 °C. The precipitate
was dried at room temperature and resuspended in TE. The amount of
DNA was measured spectrophotometrically, and 4 μg was run on an
agarose gel. Electrophoresis was carried out in 2.5% agarose gels in
buffer TBE (45 mM Tris-base, 45 mM boric acid and 1.6 mM EDTA).
Quantiﬁcation was performed by scanning the area of separation of
DNA under 10,000 bp by using ScionImage software (NIH) and the
pixels were plotted.
2.14. Data analysis
All data were expressed as mean±SD values. The statistical signif-
icance was assessed using analysis of variance (ANOVA) for multiple
comparisons and Student's t-test.
3. Results
3.1. Aminochrome uptake
We have isolated synaptic vesicles from rat brain to study the ability
of VMAT-2 to take up 3H-aminochrome. Synaptic vesicles are able to
take up 3H-aminochrome that increase with time at similar rate to 3H-
dopamine (Fig. 1A). No signiﬁcant differences between 3H-dopamine
(6.12±0.1 nmol/min/mg) and 3H-aminochrome (6.15±0.05 nmol/
min/mg) was observed when synaptic vesicles were incubated during
120 min. 3H-Dopamine (30 nM) uptake into substantia nigra synaptic
vesicles was inhibited by 10, 50, and 100 μM aminochrome (37, 45
and 67% inhibition; Pb0.05, 0.05 and 0.01, respectively). As a positive
control 10 μM dihydrotetrabenazine was used resulting in 81% inhibi-
tion of 3H-dopamine uptake (Fig. 1B). The cells incubated with 1 μM re-
serpine induced a strong inhibition of 3H-dopamine uptake (82%;
Pb0.001) while the inhibition of 3H-aminochrome uptake was lower
(23%; Pb0.01). The incubation of 1 μMreserpine at 4 °C did not increase
the uptake inhibition of 3H-dopamine (88%; Pb0.001 compared to the
control) while under these conditions 3H-aminochrome uptake was
strong inhibited (74%; Pb0.001 compared to the control). Both 3H-
dopamine and
3
H-aminochrome uptake was near complete inhibition
when 1 μM reserpine was incubated in the absence of ATP (98%,
Pb0.001 and 97%, Pb0.001, respectively) (Fig. 1C).We isolated synaptic
vesicles from rat substantia nigra in order to increase the number of
monoaminergic vesicles and we tested lobeline as inhibitor of VMAT-
2. The incubation of monoaminergic vesicles with 2 μM lobeline inhib-
ited both 3H-dopamine (56%; Pb0.01) and 3H-aminochrome (61%;
Pb0.01) uptake. Incubation of monoaminergic vesicles with 2 μM lobe-
line at 4 °C resulted in inhibition of both 3H-dopamine (91%; Pb0.001)
and 3H-aminochrome (83%; Pb0.001) uptake (Fig. 1D).
3.2. VMAT-2 and DT-diaphorase overexpression
The possible protective role of VMAT-2 and DT-diaphorase
against aminochrome neurotoxicity was studied by increasing the
expression of VMAT-2 and DT-diaphorase in RCSN-3 cells by trans-
fecting the plasmid pVMAT2GFPDT coding for the cDNA of VMAT-2fused to the C-terminal with the green ﬂuorescence protein (GFP)
and DT-diaphorase. Transfection of RCSN-3 cells with the plasmid
pVMAT2GFPDT induced a signiﬁcant increase in the expression of
VMAT-2 (7-fold; Pb0.001; Fig. 2B and C) and DT-diaphorase (9-
fold; Pb0.001; Fig. 2A and C) determined by using dot-blot tech-
nique. The transfected cells with pVMAT2GFPDT were selected by
growing the cells in the presence of 250 μg/ml geniticine obtaining
a cell line with green ﬂuorescence as it can be observed in Fig. 2D
(right). The enzymatic activity of DT-diaphorase in RCSN3VMAT2GFPDT-
cells increased in 5.5-fold (6.6±1 μmol/min/mg protein) in comparison
with wild type RCSN-3 cells (1.2±0.2 μmol/min/mg protein; Pb0.001)
and RCSN3GFP cells transfected with plasmid coding for GFP alone
(1.2±2 μmol/min/mg protein; Fig. 2E). RCSN3VMAT2GFPDTcells also
exhibited a 4-fold increase in VMAT-2 activity (Pb0.001; Fig. 2F).
3.3. Aminochrome-induced cell death
A signiﬁcant decrease in cell death was observed in RCSN3VMAT2-
GFPDT cells (5.5±0.4%) incubated with 20 μM aminochrome during
24 h in comparison with RCSN-3 cells (34±0.3%; Pb0.001) and
RCSN-3-GFP cells (29±1%; Pb0.01) incubated under the same
conditions. The inhibition of DT-diaphorase by 100 μM dicoumarol in
RCSN3VMAT2GFPDT incubated with 20 μM aminochrome increased the
cell death (24±1; Pb0.001) in comparisonwith RCSN3VMAT2GFPDT in-
cubated alone with 20 μM aminochrome, but when we compare the cell
death between RCSN-3 cells incubated with 20 μM aminochrome and
100 μM dicoumarol (42±1) with RCSN3VMAT2GFPDT incubated under
the same conditions we can observe a signiﬁcant decrease in cell death
(Pb0.001). A signiﬁcant decrease in cell death in RCSN3VMAT2GFPDT
(18±1%; Pb0.001) incubated with 2 μM lobeline and 20 μM amino-
chrome was observed in comparison with RCSN-3 cells (45±0.2%)
treated under the same conditions (Fig. 3). No signiﬁcant cell death was
observed in RCSN-3, RCSN-3-GFP and RCSN3VMAT2GFPDT cells treated
with 100 μM dicoumarol (2.9±0.1; 3.0±0.2; 6.6±1, respectively) or
2 μM lobeline (5±0.1; 2.9±1.4; 4.3±1, respectively) (data not shown).
3.4. Aminochrome effect on autophagy
Transmission electron microscopy was performed to examine cel-
lular changes at the ultrastructure level in order to obtain more infor-
mation about the mechanism of cell death induced by aminochrome
in the presence of dicoumarol or lobeline. The ultrastructure of
RCSN-3 cells incubated with 20 μM aminochrome showed autophagy
vacuoles with double membrane containing a dark pigment (Fig. 4D).
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marol show autophagy vacuoles containing remainder of organelles
such as mitochondria (Fig. 4F) or incubated with 20 μM amino-
chrome, 100 μM dicoumarol and 2 μM lobeline also show autophagy
vacuoles (Fig. 4H). However, RCSN3VMAT2GFPDT cells treated with
20 μM aminochrome (Fig. 4E); 20 μM aminochrome and 100 μM di-
coumarol (Fig. 4G); and 20 μM aminochrome and 2 μg lobeline
(Fig. 4I) showed a normal ultrastructurewithout the presence of autop-
hagy vacuoles (Fig. 4E, G and I). We analyzed the formation autophago-
some vacuoles by transfecting RCSN-3 and RCSN3VMAT2GFPDT cells
with a plasmid coding for LC3-GFP that produce green ﬂuorescence.
The treatment of RCSN-3 cells with 20 μMaminochrome; 20 μMamino-
chrome and 100 μM dicoumarol; or 20 μM aminochrome and 2 μM lo-
beline induces a signiﬁcant increase in the number LC3 positive cells
in comparison with untreated cells (25±1, Pb0.05; 37±3, Pb0.001;
39±3, Pb0.001 LC3 positive cells, respectively). The treatment with
20 μM aminochrome or 20 μM aminochrome and 100 μM dicoumarol
in RCSN3VMAT2GFPDT did not induce a signiﬁcant increase in LC3 pos-
itive cells (6±2 and 7±2), in comparison with control cells (6±2 LC3Fig. 4. Ultrastructural analysis of autophagic vacuoles in RCSN-3 and RCSN3VMAT2GFPDT c
vacuoles (white arrows) in RCSN-3 and RCSN3VMAT2GFPDT cells was determined by using
ture medium (A) 100 μM dicoumarol (B) 2 μM lobeline (C) 20 μM aminochrome (D) 20 μM
(H). RCSN3VMAT2GFPDT cells incubated with 20 μM aminochrome (E) 20 μM aminoch
(Bars=0.5 μm; nucleus N).positive cells, respectively). No signiﬁcant increase in LC3 positive cells
was observed in RCSN3VMAT2GFPDT cells treated with 20 μM amino-
chrome and 2 μM lobeline; or 20 μM aminochrome, 100 μM dicoumarol
and 2 μM lobeline (13±2 and 14±2 LC3 positive cells) in comparison
with RCSN-3 control cells (Fig. 5A). To study the role of autophagy vacu-
oles on aminochrome induced cell deathweused vinblastine that is an in-
hibitor of autophagosome fusion with lysosomes. The incubation of
RCSN-3 cells with 20 μM aminochrome in the presence of 10 μMvinblas-
tine induced a signiﬁcant increase in cell death from 38±2% to 48±5%
(Pb0.05). Incubation of RCSN-3 cells with 20 μM aminochrome together
with 100 μM dicoumarol in the presence of 10 μM vinblastine also in-
duced a signiﬁcant increase in cell death (45±1%and 51±4%Pb0.05, re-
spectively). Incubation of RCSN-3 cells with 20 μM aminochrome
together with 2 μM lobeline also induced a signiﬁcant increase cell
death in the presence of 10 μMvinblastine (61±4%; Pb0.001). However,
in RCSN3VMAT2GFPDT cells the presence of 10 μMvinblastine induced a
signiﬁcant increase only in cells treated with 20 μM aminochrome alone
(7.8±0.2% to 36±4%; Pb0.001) while no statistically signiﬁcant differ-
ences were observed when the cells were treated with 20 μMells treated with aminochrome, dicoumarol and lobeline. The formation of autophagic
transmission electron microscopy in RCSN-3 cells incubated during 24 h with cell cul-
aminochrome and 100 μM dicoumarol (F) and 20 μM aminochrome and 2 μM lobeline
rome and 100 μM dicoumarol (G) and 20 μM aminochrome and 2 μM lobeline (I).
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Fig. 5. Autophagy role in aminochrome-induced cell death in RCSN-3 and
RCSN3VMAT2GFPDT cells. (A) The effect of aminochrome on autophagy was deter-
mined by transfecting RCSN-3 and RCSN3VMAT2GFPDT cells with a plasmid coding
for LC3-GFP. A statistical signiﬁcant decrease in autophagy was observed in
RCSN3VMAT2GFPDT cells with high expression of both VMAT-2 and DT-diaphorase
in comparison with RCSN-3 cells when the cells were incubated with 20 μM amino-
chrome (AM); 20 μM aminochrome and 2 μM lobeline (AML); 20 μM aminochrome
and 100 μM dicoumarol (AMD); and 20 μM aminochrome 100 μM dicoumarol and
2 μM lobeline (AMDL). No signiﬁcant difference was observed between these cell
lines when these cells were incubated with cell culture medium in the presence (C)
and the absence of bovine serum (C+) 100 μm dicoumarol (D) 2 μM lobeline (L); (B)
the effect of vinblastine on aminochrome induced death was determined in RCSN-3
and RCSN3VMAT2GFPDT. The cells were incubated 20 μM aminochrome (AM) 20 μM
aminochrome and 10 μM vinblastine (AMV) 20 μM aminochrome and 100 μM dicou-
marol (AMD) 20 μM aminochrome 100 μM dicoumarol and 10 μM vinblastine
(AMDV) 20 μM aminochrome and 2 μM lobeline (AML) 20 μM aminochrome 2 μM lo-
beline and 10 μM vinblastine 10 μM vinblastine (V) 100 μM dicoumarol (D) and 2 μM
lobeline (L). The presence of vinblastine increased aminochrome-induced cell death
both in RCSN-3 and RCSN3VMAT2GFPDT; (C) the effect of rapamycin on aminochrome
induced death was determined in RCSN-3 and RCSN3VMAT2GFPDT. The cells were in-
cubated 20 μM aminochrome (AM), 20 μM aminochrome and 10 μM rapamycin
(AMR); 20 μM aminochrome and 100 μM dicoumarol (AMD); 20 μM aminochrome
100 μM dicoumarol and 10 μM rapamycin (AMDR); 20 μM aminochrome and 2 μM lo-
beline (AML); 20 μM aminochrome 2 μM lobeline and 10 μM rapamycin; 10 μM rapa-
mycin (R); 100 μM dicoumarol (D); 2 μM lobeline (L). The presence of rapamycin
decreased aminochrome-induced cell death both in RCSN-3 and RCSN3VMAT2GFPDT.
The statistical signiﬁcance was assessed using ANOVA for multiple comparisons and
Student's t test (*Pb0.05; **Pb0.01; ***Pb0.001).
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chrome together with 2 μM lobeline (Fig. 5B). We used also rapamy-
cin, an inducer of autophagy, to study the role of autophagy in
RCSN3VMAT2GFPDT cells (Fig. 5C). A signiﬁcant decrease in cell
death was observed in RCSN-3 cells pre-treated with 10 μM rapa-
mycin during 2 h prior addition of 20 μM aminochrome; 20 μM
aminochrome and 2 μM lobeline; or 20 μM aminochrome and100 μM dicoumarol (22±2%, Pb0.001; 32±3%, Pb0.0.01; 28±3%
cell death Pb0.01, respectively) in comparison with cells without
rapamycin pre-treatment. A signiﬁcant decrease in cell death was
also observed in RCSN3VMAT2GFPDT cells pre-treated with 10 μM
rapamycin incubated with 20 μM aminochrome and 2 μM lobeline
or 20 μM aminochrome and 100 μM dicoumarol compared with cell
without pre-treatment. However, no signiﬁcant differences were ob-
served in RCSN3VMAT2GFPDT cells pre-treated with rapamycin and
incubated with aminochrome alone in comparison with cells with-
out pre-incubation with rapamycin.3.5. Aminochrome effect on mitochondria
Dramatic changes in mitochondrial ultrastructure were observed in
RCSN-3 cells treated with 20 μM aminochrome and 100 μMdicoumarol
that included remodeling of the inner membrane conformation to a
form abnormal vesicular mitochondria structure (see Fig. 6F, white
arrow) contrasting with normal mitochondria ultra structure in
RCSN3VAMT2GFPDT cells treated under the same conditions (Fig. 6G).
RCSN-3 cells treated with 20 μM aminochrome and 2 μM lobeline also
showed a dramatic remodeling of inner mitochondrial membrane
(Fig. 6H, white head of arrows) contrasting with normal inner mem-
brane of mitochondria in RCSN3VAMT2GFPDT cells treated under
the same conditions (Fig. 6I). Normal mitochondria are observed in
RCSN-3 cells incubated with cell culture medium (Fig. 6A); 100 μM
dicoumarol (Fig. 6B); 2 μM lobeline and 20 μM aminochrome
(Fig. 6H); and in RCSN3VAMT2GFPDT cells incubated with 20 μM
aminochrome (Fig. 6E); 20 μM aminochrome and 100 μM dicouma-
rol (Fig. 6G); and 20 μM aminochrome and 2 μM lobeline (Fig. 6I).
We measured ATP level in RCSN-3 cells and we found a signiﬁcant
decrease in cells treated with 20 μM aminochrome (121±11 μM
ATP; Pb0.001); 20 μM aminochrome together with 100 μM dicou-
marol (172±6 μM ATP; Pb0.001); or 20 μM aminochrome together
with 2 μM lobeline (156±7 μM ATP; Pb0.001) in comparison with
untreated RCSN-3 cells (278±9 μM ATP). This result contrasts with
lack of signiﬁcant differences in RCSN3VAMT2GFPDT cells treated
with 20 μM aminochrome (256±11 μM ATP) compared to control
cells. A signiﬁcant decrease in ATP level was also observed in RCSN-
3 and RCSN3VAMT2GFPDT cells treated with 20 μM aminochrome
together with 100 μM dicoumarol (198±15; Pb0.001) or 20 μM
aminochrome together with 2 μM lobeline (195±25; Pb0.01). The
levels of ATP in RCSN-3 and RCSN3VAMT2GFPDT cells treated with
2 μM lobeline or 100 μM dicoumarol were 229±20, 244±8, 246±
6 and 245±4 μM ATP (Fig. 7).3.6. Aminochrome effect on DNA
We determinedwhether VMAT-2 and DT-diaphorase was protec-
tive against nuclear DNA damage in response to aminochrome treat-
ment. In RCSN3VMAT2GFPDT cells treated with cell culture medium,
nuclear DNA damage decreased relative to control RCSN-3 cells
(−0.14±0.01 lesions/10 kb; Fig. 8A). RCSN3VMAT2GFPDT cells
treated with 100 μM aminochrome also showed decreased levels of
nuclear DNA damage (0.34±0.09 lesions/10 kb) relative to RCSN-3
cells treated under the same conditions (1.2±0.01 lesions/10 kb;
Fig. 8A). We determined DNA fragmentation in cells treated with
20 μM aminochrome in the presence of 2 μM lobeline and 100 μMdi-
coumarol by using DNA laddering technique. A signiﬁcant decrease
in DNA fragmentation was observed in RCSN3VMAT2GFPDT cells in
comparison with RCSSN-3 cells treated with 20 μM aminochrome
(8.2% of control; Pb0.05); 20 μM aminochrome and 100 μM dicou-
marol (15% of control; Pb0.05); 20 μM aminochrome and 2 μM lobe-
line (57% of control; Pb0.05) and 20 μM aminochrome, 100 μM
dicoumarol and 2 μM lobeline (30% of control; Pb0.05; Fig. 8B).
Fig. 6.Mitochondria ultrastructural analysis in RCSN-3 and RCSN-3VMAT2GFPDT cells treated with aminochrome. Normal mitochondria inner membranes were observed in RCSN-
3 cells incubated during 24 h with cell culture medium (A); 100 μM dicoumarol (B); 2 μM lobeline (C) and 20 μM aminochrome (D) or in RCSN3VMAT2GFPDT cells treated with
20 μM aminochrome (E). However, remodeling of the inner membrane conformation in mitochondrial ultrastructure were observed in RCSN-3 cells treated with 20 μM amino-
chrome and 100 μM dicoumarol; (F) or 20 μM aminochrome and 2 μM lobeline; (H) contrasting with normal mitochondria ultra structure in RCSN3VMAT2GFPDT cells treated
under the same conditions (G and I) respectively. (Bars=0.5 μm; nucleus N).
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Fig. 7. The effect of aminochrome on intracellular ATP level in RCSN-3 and RCSN-
3VMAT2GFPDT cells. A signiﬁcant decrease in ATP level was observed in RCSN-3 cells
treated with 20 μM aminochrome (AM) contrasting with the lack of effect in
RCSN3VMAT2GFPDT cells treated under the same conditions. The cells were treated
with cell culture medium (C); 100 μm dicoumarol (D); 20 μM aminochrome and
100 μM dicoumarol (AMD); 2 μM lobeline (L); and 20 μM aminochrome and 2 μM lobe-
line (AML). The statistical signiﬁcance was assessed using ANOVA for multiple compar-
isons and Student's t test (**Pb0.01; ***Pb0.001).
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The molecular mechanism involved in the degeneration of the
nigro-striatal system in Parkinson's disease is still unclear. However,
it is generally accepted that mitochondrial dysfunction, aggregation
of proteins such as alpha synuclein, dysfunction of protein degrada-
tion systems, oxidative stress and neuroinﬂammation are involved
in the loss of dopaminergic neurons containing neuromelanin in
Parkinson's disease. Aging is also an important risk factor for neuro-
degenerative disorders including Parkinson's disease. Aging process
can negatively inﬂuence these molecular mechanisms that underlie
neurodegeneration in Parkinson's disease. The question is the identity
of the neurotoxin that induces the neurodegeneration of nigro-
striatal system; one may speculate that it is of endogenous origin
due to the fact that neurodegeneration and disease progression is
very slow and can take many years. The main reason why the neuro-
toxin should be of endogenous origin is that MPTP induces severe
Parkinsonism symptoms in humans only 3 days after injection [32].
Therefore, it seems plausible that an endogenous neurotoxin generat-
ed inside of dopaminergic neurons containing neuromelanin is
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Fig. 8. The effect of aminochrome on DNA. (A) Nuclear DNA damage was decreased in
RCSN3VMAT2GFPDT cells treated with 20 μM aminochrome (AM) or cell culture medi-
um (C) in comparison to RCSN-3 cells treated under the same conditions; (B) a signif-
icant decrease in DNA fragmentation was observed in cells RCSN3VMAT2GFPDT in
comparison with RCSN-3 cells treated with 20 μM aminochrome (AM); 20 μM amino-
chrome and 100 μM dicoumarol (AMD); 20 μM aminochrome and 2 μM lobeline
(AML); 20 μM aminochrome, 100 μM dicoumarol and 2 μM lobeline (AMDL). As control
the cells were treated with 2 μM lobeline (L) or 100 μM dicoumarol (D). The statistical
signiﬁcance was assessed using ANOVA for multiple comparisons and Student's t test
(***Pb0.001).
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an exogenous neurotoxin with high afﬁnity for dopamine transport
will affect extensive number of dopaminergic neurons inducing a
rapid appearance of motor symptoms. One possible candidate for en-
dogenous neurotoxin is aminochrome that is the product of dopa-
mine oxidation and the precursor of neuromelanin. Dopamine
oxidizes to dopamine o-quinone that is the precursor of amino-
chrome, which is a transient compound at physiological pH levels,
since its amino chain spontaneously at physiological undergoes cy-
clization to form aminochrome [21]. Aminochrome is able to poly-
merize to form the neuromelanin pigment that is present in
dopaminergic neurons. Neuromelanin accumulates with age [6,7]and it seems to be a normal event since dopaminergic neurons con-
tain neuromelanin are present in individuals without the disease.
Neuromelanin accumulates in double membrane vesicles where it
plays a clear neuroprotective role while free neuromelanin has
been found to induce neuroinﬂammation and neurodegeneration
[33,34]. However, aminochrome is able to induce neurotoxicity by
the following reactions: (i) the formation of adducts with proteins
such as alpha synuclein [10,11], with the complexes I and III of the
electron transport chain in mitochondria [12], with actin and α- and
β-tubulin [15]. In addition, aminochrome inactivates parkin, that is a
ubiquitin ligase 3 [35], tyrosine hydroxylase and human dopamine
transporter [36,37]; and (ii) its one-electron reduction leukoamino-
chrome o-semiquinone radical with concomitant formation of superox-
ide, hydrogen peroxide and hydroxyl radical [16,23], inducing a redox
cycling depleting NADH and oxygen required for ATP production. Ami-
nochrome has been proposed to be the endogenous neurotoxin respon-
sible of the slow and progressive neurodegeneration of dopaminergic
neurons containing neuromelanin [23,38]. VMAT-2mediated dopamine
uptake into monoaminergic vesicles and therefore, will prevent dopa-
mine oxidation and aminochrome neurotoxicity and DT-diaphorase
prevents aminochrome one-electron reduction and the formation of ad-
ducts with proteins. Therefore, to study the protective role of VMAT-2
and DT-diaphorase against aminochrome neurotoxicity, we designed a
plasmid containing an internal ribosome entry site (IRES) for co-
expression of VMAT-2 fused to eGFP and DT-diaphorase. The expression
of VMAT-2 andDT-diaphorase in RCSN3VMAT2GFPDT cells increased 7-
and 9-fold and their activity increased in near 4- and 6-fold in compar-
ison to RCSN-3 cells, respectively. This cell line seemed to be a good
model cell line to study VMAT-2 and DT-diaphorase protective role in
dopaminergic neurons (Fig. 9).
There are three ways to prevent aminochrome neurotoxicity: (i)
preventing dopamine oxidation to aminochrome. In dopaminergic
neurons, the intracellular dopamine is efﬁciently incorporated into
monoaminergic vesicles by VMAT-2 for neuronal transmission or
storage. Therefore, VMAT-2 mediated dopamine uptake into mono-
aminergic vesicles should be considered as a very important neuro-
protective mechanism in dopaminergic neurons since the low pH
inside the monoaminergic vesicles prevent dopamine oxidation to
aminochrome. Dopamine synthesis occurs at the synaptic terminal
catalyzed ﬁrst by tyrosine hydroxylase that converts tyrosine to L-
dopa and secondly aromatic amino acid decarboxylase that converts
L-dopa to dopamine. There is evidence that VMAT-2 physically and
functionally interacts with the enzymes responsible for DA synthesis
[39], preventing the existence of free dopamine in the cytosol. How-
ever, the uptake of dopamine released during neurotransmission
mediated by dopamine transporter will provide free intracellular do-
pamine but VMAT-2 will transport this dopamine into monoaminer-
gic vesicles. Another mechanism to prevent free cytosolic dopamine
is mediated by monoamino oxidase that is able to degrade free cyto-
solic dopamine by catalyzing the oxidative deamination of dopamine
with concomitant formation of hydrogen peroxide. Inhibition of
monoamine oxidase has been used in Parkinson's disease treatment
in order to inhibit dopamine degradation [40]. Another mechanism
to prevent accumulation of free cytosolic dopamine is the formation
of neuromelanin [9]; (ii) preventing aminochrome participation in
neurotoxic reactions such as adducts formation with proteins and
one-electron reduction. Our results revealed that VMAT-2 is able to
take up aminochrome at a similar rate as dopamine suggesting that
VMAT-2 plays a double protective role against aminochrome
neurotoxicity by preventing dopamine oxidation to aminochrome
in the cytosol and by transporting cytosolic aminochrome into
monoaminergic vesicles where aminochrome cannot form adducts
with proteins or be one-electron reduced; and (iii) preventing one-
electron reduction to leukoaminochrome o-semiquinone radical
which is extremely reactive with oxygen by two-electron reduction
of aminochrome catalyzed by DT-diaphorase [16,24,23]. DT-
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Fig. 9. Possible role of VMAT-2 and DT-diaphorase in aminochrome neurotoxicity. (A) RCSN3VMAT2GFPDT cells with overexpression of VMAT-2 and DT-diaphorase prevent ami-
nochrome neurotoxicity by transporting aminochrome into monoaminergic vesicles catalyzed by VMAT-2 a reaction that requires ATP and/or by reducing aminochrome with two-
electron catalyzed by DT-diaphorase. These two enzymes provides protection against aminochrome neurotoxicity; (B) RCSN-3 cells with constitutive level of expression of VMAT-2
and DT-diaphorase or when VMAT-2 and DT-diaphorase are inhibited by lobeline (reaction 1) and dicoumarol (reaction 2) respectively aminochrome is able to (i) form adducts
with proteins such as complex I and complex III of electron transport chain in mitochondria inhibiting ATP production in mitochondria (reaction 5); (ii) damage DNA and subse-
quent fragmentation (reaction 6); (iii) be one-electron reduced catalyzed by ﬂavoenzymes that use NADH as a electron donator generating leukoaminochrome o-semiquinone rad-
ical (reaction 3) that is extremely reactive with oxygen creating a redox cycling between aminochrome and leukoaminochrome o-semiquinone radical (reaction 4) that continues
until NADH and oxygen are depleted affecting the ATP production in the electron transport chain. Aminochrome can also be one-electron reduced by ﬂavoenzymes that use NADP
as electron donator resulting in the depletion of NADPH required for several biosynthetic reaction and reduction of oxidized glutathione. All these reactions ﬁnally induce cell death.
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sequent redox cycle between aminochrome and the leukoamino-
chrome o-semiquinone radical [41,42]. This redox cycle depletes
NADH when ﬂavoenzymes use NADH as electron donor during
one-electron reduction of aminochrome inducing an energy collapse
since NADH is required for ATP synthesis in the mitochondria. Our
results support this idea since RCSN-3 cells incubated with amino-
chrome induced a signiﬁcant decrease in ATP level (50%). DT-
Diaphorase also prevents the formation of neurotoxic protoﬁbrils
during the formation of aminochrome adducts with alpha-
synuclein [25,26]. DT-Diaphorase prevents the cytoskeleton disrup-
tion by preventing actin, α-tubulin and β-tubulin aggregation [10].
DT-Diaphorase also prevents mitochondrial damage [16,24] and
aminochrome-induced proteasome inhibition [13].
Overexpression of VMAT-2 and DT-diaphorase in RCSN3VMAT2-
GFPDT cells prevents ultrastructure damage in the presence of amino-
chrome since (i) ultrastructure of mitochondria was preserved in
contrast to RCSN-3 cells showing remodeling of the innermembrane con-
formation. The lack of damage ofmitochondriawas also supported by the
lack of effect of aminochrome on ATP level in RCSN3VMAT2GFPDTcells
contrasting with a signiﬁcant decrease of ATP level in RCSN-3 cells; (ii)
the autophagy level in RCSN3VMAT2GFPDT cells treated with amino-
chrome was similar as the constitutive level of cells treated with cell cul-
ture medium determined by transmission electron microscopy and LC3-
GFP positive autophagosome, suggesting that the incubation of cells
with overexpression of both VMAT-2 and DT-diaphorase with amino-
chromedonot require an increase in autophagy. Autophagy is an intracel-
lular degradation mechanism whereby organelles and proteins are
transported by autophagy vacuoles into lysosomes for degradation and
recycling [43–45]. Autophagy plays an important role in the elimination
of damaged organelles such as mitochondria. It has been reported that
aminochrome induces autophagy [23]. An interesting ﬁnding from analy-
sis of ultrastructure with transmission electron microscopy is the forma-
tion of a dark pigment inside of double membrane autophagy vacuoles
in RCSN-3 cells treated both with aminochrome and an inhibitor of DT-
diaphorase, contrasting with the lack of pigment in RCSN-3 cells
incubated without DT-diaphorase inhibitor. These results suggest that
DT-diaphorase inhibition preventing two-electron reduction of amino-
chrome is important for formation of neuromelanin.
To determine the role of autophagy on aminochrome-induced cell
death in RCSN-3 and RCSN3VMAT2GFPDT cells we used vinblastine, an
inducer of autophagosome accumulation by blocking the fusion of
autophagy vacuoles and lysosomes [46] and rapamycin, an inducer of
macroautophagy by inactivating mTor pathway [47]. In RCSN-3 cells
aminochrome induces an increase in cell death in the presence of vin-
blastine and a decrease in cell death in the presence of rapamycin as it
was expected [23]. However, in RCSN3VMAT2GFPDT cells aminochrome
induces an increase in cell death in the presence of vinblastine but no
signiﬁcant differences were observed when the cells were incubated
with rapamycin. A possible explanation for the lack of effect of rapamy-
cin on cell death can be explained by low level of cell death induced by
aminochrome (7±1%) as a consequence of the protective effect of
VMAT-2 and DT-diaphorase overexpression. Vinblastine induces an in-
crease in aminochrome-dependent cell death both in RCSN-3 or
RCSN3VMAT2GFPDT cells when DT-diaphorase was inhibited by dicou-
marol and a decrease in cell death in the presence of rapamycin support-
ing the protective role of autophagy in aminochrome neurotoxicity [23].
However, vinblastine did not increase the cell death in RCSN3VMAT2-
GFPDT cells treated with aminochrome and lobeline, a result that we
still have no explanation. Rapamycin induces a decrease in cell death
both in RCSN-3 or RCSN3VMAT2GFPDT cellswhenVMAT-2was inhibited
by lobeline suggesting that autophagy protect against aminochrome
neurotoxicity.
Our results may explain why VMAT2-deﬁcient in mice induces a
progressive neurodegeneration in the substantia nigra coupled with
α-synuclein accumulation [48,18] since a deﬁciency or knockdownof VMAT-2 will result in accumulation of free cytosolic dopamine
[49] that autoxidizes to aminochrome inducing neurodegeneration
accompanied with accumulation of α-synuclein aggregation. The in-
crease in aminochrome concentration plays an important role in α-
synuclein aggregation since aminochrome induces and stabilizes the
formation of α-synuclein protoﬁbers [10,11]. Exposure of mice with
low expression of VMAT-2 (5–10%) to methamphetamine exacer-
bates the loss of dopamine transporter and tyrosine hydroxylase, ac-
companied with an increase in astrogliosis and protein carbonyl
formation [50], probably as a consequence of dopamine release in-
duced by methamphetamine [51]. VMAT2+/−mice were more sen-
sitive to the neurotoxic effects of MPTP, since the VMAT2-mediated
uptake of the neurotoxin into vesicles may play an important role in
attenuating MPTP toxicity in vivo [52]. On the other side high-level
expression of rat VMAT-2 induced resistance to MPTP metabolite
MPP+ [53]. VMAT-2 has two binding sites, one with high afﬁnity
for reserpine and another one with high afﬁnity to dihydrotetrabena-
zine and low afﬁnity for reserpine [54]. Aminochrome uptake mediat-
ed by VMAT-2 was inhibited by lobeline but not reserpine while
dopamine was inhibited by both VMAT-2 inhibitors. Lobeline is an in-
hibitor of VMAT-2 that speciﬁcally interacts on the dihydrotetrabena-
zine binding site to inhibit dopamine uptake into synaptic vesicles
[55]. Our results also show that aminochrome prevents dopamine up-
take into monoaminergic vesicles, increasing free cytosolic dopamine
and its subsequent oxidation to aminochrome.
5. Conclusions
Our data show that overexpression of VMAT-2 and DT-diaphorase in
RCSN3VMAT2GFPDT cells (i) strongly decreases the aminochrome-
induced cell death; (ii) prevents mitochondria inner membrane remo-
deling; (iii) prevents a decrease in ATP level; (iii) decreases level of
autophagy; (iv) decreases DNA laddering; and (v) decreases nDNA
damage. Therefore, our results support the idea that VMAT-2 and DT-
diaphorase are an important cellular defense against aminochrome-
dependent neurotoxicity that could increase vulnerability of neuromela-
nin containing neurons of the substantia nigra, neurons that selectively
degenerate during Parkinson's disease. Neuromelanin formation itself
is not a toxic pathway, since this pigment is present in the substantia
nigra of individuals not affected with Parkinson's disease, but it is
depending on the existence of a defense mechanism such as VMAT-2
and DT-diaphorase that prevent that aminochrome participates in neu-
rotoxic reactions.
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